Acasti Pharma Inc. announced that on May 8, 2023, the Company terminated the employment of Brian Ford, Chief Financial Officer. Mr. Ford will remain as interim Chief Financial Officer of the Company until June 30, 2023, subject to potential extension of that term by the Company. Under the terms of their employment arrangements Mr. Ford will receive severance payments.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.85 USD | +2.52% | -1.72% | -1.38% |
Feb. 12 | Acasti Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
Feb. 07 | Craig-Hallum Initiates Acasti Pharma With Buy Rating, $6 Price Target | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.38% | 26.79M | |
+33.25% | 699B | |
+29.01% | 571B | |
-3.55% | 364B | |
+18.16% | 326B | |
+4.36% | 286B | |
+14.94% | 236B | |
+5.02% | 198B | |
-10.72% | 194B | |
-3.69% | 149B |
- Stock Market
- Equities
- ACST Stock
- News Acasti Pharma Inc.
- Acasti Pharma Inc. Terminates the Employment of Brian Ford, Chief Financial Officer